Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Stephen Vang

Physician Assistant, Medical Sartell, MN Physician Assistant

NPI 1366755415 CMS profile 243125

166 19Th St S, Suite 101, Sartell, MN 56377

Open in the dashboard

General payments

$1,215

52 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stephen Vang of Sartell, MN is reported in the CMS Open Payments database as having received $1,215 across 52 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $311 15
2024 General $303 18
2023 General $481 12
2022 General $39 2
2021 General $81 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Vang
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Stephen Vang were reported at $311. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Stephen Vang Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $81 $156 $41–$563 $132
2022 $39 $185 $55–$649 $149
2023 $481 $199 $58–$717 $160
2024 $303 $206 $62–$740 $164
2025 $311 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $743 33 payments
  2. Abbott Laboratories $221 11 payments
  3. Relievant Medsystems, Inc. $113 2 payments
  4. SI-BONE, Inc. $37 1 payment
  5. Curonix LLC $36 2 payments
  6. SPR Therapeutics, Inc $32 1 payment
  7. AbbVie, Inc. $20 1 payment
  8. Hikma Pharmaceuticals USA $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,077 50 payments
  2. Travel and Lodging $124 1 payment
  3. Education $14 1 payment
Products named General payments · program years 2021–2025
  1. WaveWriter Alpha Prime 16 $184 12 payments
  2. Intracept Pain $105 1 payment
  3. Intracept Pain $105 1 payment
  4. Intracept Pain $105 1 payment
  5. Intracept Pain $105 1 payment
  6. PROCLAIM Neuromodulation $87 5 payments
  7. NA $83 4 payments
  8. PROCLAIM Neuromodulation $50 2 payments
  9. PROCLAIM Structural Heart $44 2 payments
  10. Superion $40 2 payments
  11. Other $324 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

1,767

Median for Physician Assistant: 241

Drug cost

$74,171

Median for Physician Assistant: $4,110

Branded share of claims

51%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycontin Oxycodone Hcl Brand 35 $21,926
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 344 $9,116
Buprenorphine Generic 44 $8,924
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 304 $8,750
Xtampza Er Oxycodone Myristate Brand 17 $6,390
Oxycodone Hcl Generic 249 $3,971
Morphine Sulfate Er Morphine Sulfate Brand 202 $3,954
Gabapentin Generic 177 $2,692
Fentanyl Generic 46 $1,620
Tizanidine Hcl Generic 111 $1,468

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$69,880

Of which drugs: $252

Medicare patients

222

Average age 67

Services billed

2,810

132 women, 90 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Depression 47%
Diabetes 26%
Ischemic heart disease 23%
Chronic kidney disease 19%
COPD 18%
Heart failure 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 37 1,603 $161
Injection, methylprednisolone acetate, 40 mg J1030 Office 15 20 $91

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
QULIPTA
  • AbbVie, Inc. $10
$10 — —
BOTOX
  • AbbVie, Inc. $10
$10 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

52 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record